Published in Ann Oncol on July 28, 2008
Influenza vaccines: from surveillance through production to protection. Mayo Clin Proc (2010) 1.09
Immunogenicity of an inactivated monovalent 2009 influenza A (H1N1) vaccine in patients who have cancer. Oncologist (2012) 0.90
Influenza vaccination and associated factors among Korean cancer survivors : a cross-sectional analysis of the Fourth & Fifth Korea National Health and Nutrition Examination Surveys. J Korean Med Sci (2014) 0.83
Immunogenicity of influenza vaccine in colorectal cancer patients. Cancer Res Treat (2013) 0.82
Influenza vaccination in cancer patients undergoing systemic therapy. Clin Med Insights Oncol (2014) 0.81
Low immunogenicity of seasonal trivalent influenza vaccine among patients receiving docetaxel for a solid tumour: results of a prospective pilot study. Br J Cancer (2011) 0.81
Practices and predictors of 2009 H1N1 vaccination in cancer patients: a nationwide survey in Korea. Influenza Other Respir Viruses (2012) 0.79
Why coverage of influenza vaccine is not enough in patients receiving chemotherapy? Int J Prev Med (2011) 0.79
Vaccination of oncology patients: an effective tool and an opportunity not to be missed. Oncologist (2012) 0.76
Influenza vaccine immunogenicity in patients with primary central nervous system malignancy. Neuro Oncol (2014) 0.75
Immunogenicity of Influenza Vaccination in Patients With Cancer. Am J Clin Oncol (2015) 0.75
Immunogenicity of trivalent influenza vaccine in patients with lung cancer undergoing anticancer chemotherapy. Hum Vaccin Immunother (2016) 0.75
Vaccination recommendations for the hematology and oncology and post-stem cell transplant populations. J Adv Pract Oncol (2012) 0.75
Vaccination of chemotherapy patients-effect of guideline implementation. Support Care Cancer (2015) 0.75
Low-Cost Intervention to Increase Influenza Vaccination Rate at a Comprehensive Cancer Center. J Cancer Educ (2017) 0.75
Vaccination in oncology practice and predictors. Support Care Cancer (2017) 0.75
Phase II study of ecteinascidin-743 in advanced pretreated soft tissue sarcoma patients. J Clin Oncol (2004) 2.15
Tuberculosis in HIV-infected patients: a comprehensive review. Clin Microbiol Infect (2004) 2.13
FORRepeats: detects repeats on entire chromosomes and between genomes. Bioinformatics (2003) 2.07
Management of hypertension in angiogenesis inhibitor-treated patients. Ann Oncol (2009) 2.06
Human T-cell lymphotropic virus-1-positive T-cell leukemia/lymphoma in a child. Report of a case and review of the literature. Arch Pathol Lab Med (1997) 1.45
Pharmacokinetics and toxicity of docetaxel: role of CYP3A, MDR1, and GST polymorphisms. Clin Pharmacol Ther (2006) 1.38
Antitumoral effect of the bisphosphonate zoledronic acid against visceral metastases in an adrenocortical cancer patient. Ann Oncol (2009) 1.38
Knowledge, attitudes and vaccination coverage of healthcare workers regarding occupational vaccinations. Vaccine (2009) 1.38
Efficacy of venlafaxine for the prevention and relief of oxaliplatin-induced acute neurotoxicity: results of EFFOX, a randomized, double-blind, placebo-controlled phase III trial. Ann Oncol (2011) 1.35
Ecteinascidin-743: a marine-derived compound in advanced, pretreated sarcoma patients--preliminary evidence of activity. J Clin Oncol (2001) 1.26
Sarcopenia and body mass index predict sunitinib-induced early dose-limiting toxicities in renal cancer patients. Br J Cancer (2013) 1.26
Primary non-Hodgkin's lymphomas of the liver with nodular and diffuse infiltration patterns have different prognoses. Ann Oncol (2001) 1.22
Diagnostic contribution of positron emission tomography with [18F]fluorodeoxyglucose for invasive fungal infections. Clin Microbiol Infect (2011) 1.20
Severe CPT-11 toxicity in patients with Gilbert's syndrome: two case reports. Ann Oncol (1997) 1.18
High-dose intrathecal trastuzumab for leptomeningeal metastases secondary to HER-2 overexpressing breast cancer. Ann Oncol (2008) 1.17
Validation of an HPLC-UV method for sorafenib determination in human plasma and application to cancer patients in routine clinical practice. J Pharm Biomed Anal (2009) 1.16
Emerging therapeutic options for breast cancer chemotherapy during pregnancy. Ann Oncol (2007) 1.11
Blood pressure monitoring in patients receiving bevacizumab. Ann Oncol (2013) 1.09
Advanced chondrosarcomas: role of chemotherapy and survival. Ann Oncol (2013) 1.08
Risk factors for major infections in Wegener granulomatosis: analysis of 113 patients. Ann Rheum Dis (2008) 1.08
Taxanes for breast cancer during pregnancy: a systematic review. Ann Oncol (2009) 1.08
The role of cell cycle regulation and apoptosis triggering in determining the sensitivity of leukemic cells to topoisomerase I and II inhibitors. Leukemia (1995) 1.07
Prostate-specific antigen doubling time before onset of chemotherapy as a predictor of survival for hormone-refractory prostate cancer patients. Ann Oncol (2007) 1.05
Zinc transporter (ZnT)8(186-194) is an immunodominant CD8+ T cell epitope in HLA-A2+ type 1 diabetic patients. Diabetologia (2012) 1.03
Cyclooxygenase 2 selective inhibitor induced bowel stricture: a case report. Gut (2004) 1.01
The changing clinical aspects of infective endocarditis: descriptive review of 90 episodes in a French teaching hospital and risk factors for death. J Infect (2002) 1.01
The chemotherapy of metastatic gastric adenocarcinomas with hypersecretion of alpha-fetoprotein or beta-human chorionic gonadotrophin: report of two cases. Ann Oncol (2002) 1.01
2012/13 influenza vaccine effectiveness against hospitalised influenza A(H1N1)pdm09, A(H3N2) and B: estimates from a European network of hospitals. Euro Surveill (2015) 0.98
Immunogenicity and safety of the influenza A H1N1v 2009 vaccine in cancer patients treated with cytotoxic chemotherapy and/or targeted therapy: the VACANCE study. Ann Oncol (2011) 0.97
Antiemetic neurokinin-1 antagonist aprepitant and ifosfamide-induced encephalopathy. Ann Oncol (2007) 0.97
Combination of oxaliplatin plus irinotecan in patients with gastrointestinal tumors: results of two independent phase I studies with pharmacokinetics. J Clin Oncol (1999) 0.97
Targeted therapies in lung cancer. Ann Oncol (2007) 0.96
Acute exacerbation of hemorrhagic rectocolitis during antiangiogenic therapy with sunitinib and sorafenib. Ann Oncol (2008) 0.96
Clinical pharmacodynamic factors in docetaxel toxicity. Br J Cancer (2007) 0.94
Severe hemolytic uremic syndrome in an advanced ovarian cancer patient treated with carboplatin and gemcitabine. Anticancer Drugs (1999) 0.92
Anthracyclines during pregnancy: embryo-fetal outcome in 160 patients. Ann Oncol (2004) 0.92
Cellular pharmacology of the combination of the DNA topoisomerase I inhibitor SN-38 and the diaminocyclohexane platinum derivative oxaliplatin. Clin Cancer Res (1999) 0.92
Reversible tumor growth acceleration following bevacizumab interruption in metastatic colorectal cancer patients scheduled for surgery. Ann Oncol (2008) 0.91
Evaluation of the nutritional and inflammatory status in cancer patients for the risk assessment of severe haematological toxicity following chemotherapy. Ann Oncol (2003) 0.91
Hypertension as a surrogate marker for the activity of anti-VEGF agents. Ann Oncol (2009) 0.90
The inferior non recurrent laryngeal nerve: a major surgical risk during thyroidectomy. Acta Chir Belg (2000) 0.89
Ecteinascidin 743 induces protein-linked DNA breaks in human colon carcinoma HCT116 cells and is cytotoxic independently of topoisomerase I expression. Clin Cancer Res (2001) 0.88
Relationship between cytochrome 3A activity, inflammatory status and the risk of docetaxel-induced febrile neutropenia: a prospective study. Ann Oncol (2006) 0.88
Tumor invasion induced by oxidative stress is dependent on membrane ADAM 9 protein and its secreted form. Int J Cancer (2010) 0.88
[Adamantinoma of the proximal end of the tibia. A case]. Presse Med (1994) 0.87
Phase I study of BIBF 1120 with docetaxel and prednisone in metastatic chemo-naive hormone-refractory prostate cancer patients. Br J Cancer (2011) 0.87
Relationship between GSTP1 Ile(105)Val polymorphism and docetaxel-induced peripheral neuropathy: clinical evidence of a role of oxidative stress in taxane toxicity. Ann Oncol (2009) 0.87
Topotecan preceded by oxaliplatin using a 3 week schedule: a phase I study in advanced cancer patients. Eur J Cancer (2002) 0.84
Low skeletal muscle is associated with toxicity in patients included in phase I trials. Invest New Drugs (2013) 0.84
Role of the lean body mass and of pharmacogenetic variants on the pharmacokinetics and pharmacodynamics of sunitinib in cancer patients. Invest New Drugs (2014) 0.84
Low influenza-vaccination rate among adults receiving immunosuppressive therapy for systemic inflammatory disease. Ann Rheum Dis (2008) 0.83
Nodular lesions of the liver revealing multiple myeloma. Leuk Lymphoma (1999) 0.83
Vaccination coverage among medical residents in Paris, France. Clin Microbiol Infect (2012) 0.83
Accidental blood exposures among medical residents in Paris, France. Clin Microbiol Infect (2011) 0.83
Sorafenib-induced diarrhea and hypophosphatemia: mechanisms and therapeutic implications. Ann Oncol (2011) 0.82
Low immunogenicity of seasonal trivalent influenza vaccine among patients receiving docetaxel for a solid tumour: results of a prospective pilot study. Br J Cancer (2011) 0.81
Genistein resistance in human leukaemic CCRF-CEM cells: selection of a diploid cell line with reduced DNA topoisomerase II beta isoform. Biochem Pharmacol (1995) 0.81
[Rare ovarian tumours: therapeutic strategies in 2010, national website observatory for rare ovarian cancers and delineation of referent centers in France]. Bull Cancer (2010) 0.81
Sorafenib in advanced melanoma: a critical role for pharmacokinetics? Br J Cancer (2012) 0.81
Isoforms of myosin and actin in human, monkey and rat myometrium. Comparison of pregnant and non-pregnant uterus proteins. Eur J Biochem (1986) 0.81
Factors influencing zidovudine efficacy when administered at early stages of Friend virus infection in mice. Antiviral Res (1991) 0.80
Efficacy of environmental measures to decrease the risk of hospital-acquired aspergillosis in patients hospitalised in haematology wards. Clin Microbiol Infect (2006) 0.80
Vaccination in adults with auto-immune disease and/or drug related immune deficiency: results of the GEVACCIM Delphi survey. Vaccine (2009) 0.80
Coexistent nontoxic lingual and median-cervical ectopic thyroid. Surgical management. JAMA (1966) 0.80
Clinical benefit in patients with metastatic bone disease: results of a phase 3 study of denosumab versus zoledronic acid. Ann Oncol (2012) 0.79
The organotelluride catalyst LAB027 prevents colon cancer growth in the mice. Cell Death Dis (2011) 0.79
Pitfalls in anti-influenza T cell detection by Elispot using thimerosal containing pandemic H1N1 vaccine as antigen. J Immunol Methods (2012) 0.79
Exacerbation of oxaliplatin neurosensory toxicity following surgery. Ann Oncol (2002) 0.79
Chronotherapy of colorectal cancer metastases. Hepatogastroenterology (2001) 0.79